Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylmâ˘
(NASDAQ:AQST) WARREN, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (âAquestiveâ or the âCompanyâ), a pharmaceutical company advancing medicines to bring me...